查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411480

血液和血漿成分市場：按產品、應用和最終用戶分類 - 2024-2030 年全球預測

Blood & Plasma Components Market by Product (Plasma-Derived, Transfusion), Application (Hematology, Solid Tumor Management), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年血液和血漿成分市場規模為438.4億美元，預計2024年將達到458.6億美元，2030年將達到641.1億美元，複合年成長率為5.57%。

全球血液和血漿成分市場

主要市場統計
基準年[2023] 438.4億美元
預測年份 [2024] 458.6億美元
預測年份 [2030] 641.1億美元
複合年成長率（%） 5.57%
血液和血漿成分市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估血液和血漿組成市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血液和血漿成分市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-血液和血漿成分市場的市場規模和預測是多少？

2-血液和血漿成分市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-血液和血漿成分市場的技術趨勢和法律規範是什麼？

4-血液和血漿成分市場主要供應商的市場佔有率是多少？

5-進入血液和血漿成分市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著外科手術數量的增加，對安全手術的需求也增加了血液和血漿成分。
      • 政府鼓勵血液和血漿捐贈宣傳活動的舉措
      • 改善血液相關疾病及輸血醫學
    • 抑制因素
      • 血液和血漿製品的儲存和保存期限的限制
    • 機會
      • 血液採集、處理和儲存技術的進步
      • 新推出免疫球蛋白替代療法和濃縮凝血因子
    • 任務
      • 嚴格監管確保血液及血漿製品安全和品質
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章血液與血漿成分市場：依產品

  • 血漿衍生的
  • 輸血

第7章血液與血漿成分市場：依應用分類

  • 血液學
  • 固態腫瘤的治療

第8章血液和血漿成分市場：按最終用戶分類

  • 診斷實驗室
  • 醫院
  • 調查機構
  • 專科診所

第9章美洲血液和血漿成分市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太血液與血漿成分市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的血液和血漿成分市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • Alfa Laval Corporate AB
    • ANZCO Foods Limited
    • Beckman Coulter, Inc.
    • Becton, Dickinson & Co.
    • Bio-Rad Laboratories, Inc.
    • BioChemed Services
    • bioMerieux SA
    • Biowest Company
    • CSL Behring LLC.
    • Grifols, SA
    • Immucor
    • Lake Immunogenics, Inc.
    • LAMPIRE Biological Laboratories, Inc.
    • MacoPharma
    • Meiji Holdings Co., Ltd.
    • Moregate Biotech
    • Octapharma AG
    • Pel-Freez, LLC
    • Rockland Immunochemicals, Inc. by BroadOak Capital Partners
    • Sanquin
    • TCS Biosciences Ltd.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-5C6F41F5AFA7

[194 Pages Report] The Blood & Plasma Components Market size was estimated at USD 43.84 billion in 2023 and expected to reach USD 45.86 billion in 2024, at a CAGR 5.57% to reach USD 64.11 billion by 2030.

Global Blood & Plasma Components Market

KEY MARKET STATISTICS
Base Year [2023] USD 43.84 billion
Estimated Year [2024] USD 45.86 billion
Forecast Year [2030] USD 64.11 billion
CAGR (%) 5.57%
Blood & Plasma Components Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood & Plasma Components Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood & Plasma Components Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood & Plasma Components Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Laval Corporate AB, ANZCO Foods Limited, Beckman Coulter, Inc., Becton, Dickinson & Co., Bio-Rad Laboratories, Inc., BioChemed Services, bioMerieux SA, Biowest Company, CSL Behring LLC., Grifols, S.A., Immucor, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., MacoPharma, Meiji Holdings Co., Ltd., Moregate Biotech, Octapharma AG, Pel-Freez, LLC, Rockland Immunochemicals, Inc. by BroadOak Capital Partners, Sanquin, and TCS Biosciences Ltd..

Market Segmentation & Coverage

This research report categorizes the Blood & Plasma Components Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Plasma-Derived
    • Transfusion
  • Application
    • Hematology
    • Solid Tumor Management
  • End User
    • Diagnostics Laboratories
    • Hospitals
    • Research Institutions
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood & Plasma Components Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood & Plasma Components Market?

3. What are the technology trends and regulatory frameworks in the Blood & Plasma Components Market?

4. What is the market share of the leading vendors in the Blood & Plasma Components Market?

5. Which modes and strategic moves are suitable for entering the Blood & Plasma Components Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Blood & Plasma Components Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of surgical procedures and need for safe blood & plasma components
      • 5.1.1.2. Government initiatives encouraging blood & plasma donation campaigns
      • 5.1.1.3. Improvements in blood-related disorders and transfusion medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations associated with storage and shelf life of blood & plasma products
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in blood collection, processing, and storage technologies
      • 5.1.3.2. Emerging adoption of immunoglobulin replacement therapy and clotting factor concentrates
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations to ensure the safety & quality of blood & plasma products
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Blood & Plasma Components Market, by Product

  • 6.1. Introduction
  • 6.2. Plasma-Derived
  • 6.3. Transfusion

7. Blood & Plasma Components Market, by Application

  • 7.1. Introduction
  • 7.2. Hematology
  • 7.3. Solid Tumor Management

8. Blood & Plasma Components Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostics Laboratories
  • 8.3. Hospitals
  • 8.4. Research Institutions
  • 8.5. Specialty Clinics

9. Americas Blood & Plasma Components Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood & Plasma Components Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood & Plasma Components Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Alfa Laval Corporate AB
    • 13.1.3. ANZCO Foods Limited
    • 13.1.4. Beckman Coulter, Inc.
    • 13.1.5. Becton, Dickinson & Co.
    • 13.1.6. Bio-Rad Laboratories, Inc.
    • 13.1.7. BioChemed Services
    • 13.1.8. bioMerieux SA
    • 13.1.9. Biowest Company
    • 13.1.10. CSL Behring LLC.
    • 13.1.11. Grifols, S.A.
    • 13.1.12. Immucor
    • 13.1.13. Lake Immunogenics, Inc.
    • 13.1.14. LAMPIRE Biological Laboratories, Inc.
    • 13.1.15. MacoPharma
    • 13.1.16. Meiji Holdings Co., Ltd.
    • 13.1.17. Moregate Biotech
    • 13.1.18. Octapharma AG
    • 13.1.19. Pel-Freez, LLC
    • 13.1.20. Rockland Immunochemicals, Inc. by BroadOak Capital Partners
    • 13.1.21. Sanquin
    • 13.1.22. TCS Biosciences Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BLOOD & PLASMA COMPONENTS MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD & PLASMA COMPONENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD & PLASMA COMPONENTS MARKET DYNAMICS
  • FIGURE 7. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BLOOD & PLASMA COMPONENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SOLID TUMOR MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 144. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. BLOOD & PLASMA COMPONENTS MARKET LICENSE & PRICING